Principia Wealth Advisory’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57K Buy
17
+9
+113% +$3.34K ﹤0.01% 307
2026
Q1
$2.34K Sell
8
-8
-50% -$2.63K ﹤0.01% 474
2025
Q4
$5.61K Buy
16
+3
+23% +$1.01K ﹤0.01% 253
2025
Q3
$4.2K Buy
13
+4
+44% +$1.24K ﹤0.01% 296
2025
Q2
$3.5K Buy
9
+2
+29% +$804 ﹤0.01% 285
2025
Q1
$3.05K Hold
7
﹤0.01% 236
2024
Q4
$2.58K Buy
+7
New +$2.93K ﹤0.01% 205

Other funds holding ELV

Principia Wealth Advisory's ELV Position: Q2 2026 in Review

Principia Wealth Advisory increased its Elevance Health (ELV) stake by 113% in Q2 2026, buying an estimated $3.34K and bringing the position to 17 shares worth $6.57K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

Principia Wealth Advisory first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Principia Wealth Advisory held 17 shares of Elevance Health worth $6.57K as of Q2 2026.
  • Principia Wealth Advisory bought 9 Elevance Health shares in Q2 2026, an estimated $3.34K.
  • Elevance Health made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #307 holding.
  • Principia Wealth Advisory first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.